Skip to main content
Ronald Buckanovich, MD, Oncology, Ann Arbor, MI

RonaldJBuckanovichMD

Oncology Ann Arbor, MI

Physician

Dr. Buckanovich is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Buckanovich's full profile

Already have an account?

  • Office

    1500 E Medical Center Dr
    B1 floor Cancer Recp C
    Ann Arbor, MI 48109
    Phone+1 734-647-8906

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2001 - 2004
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Internal Medicine, 1998 - 2001
  • Weill Cornell Medicine
    Weill Cornell MedicineClass of 1998

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 1999 - 2026
  • MI State Medical License
    MI State Medical License 2006 - 2019
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • Elected Member The American Society for Clinical Investigation, 2012
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Leukemia Inhibitory Factor Functions in Parallel with Interleukin-6 to Promote Ovarian Cancer Growth  
    Karen McLean, Ronald J Buckanovich, Moshe Talpaz, Nature

Lectures

  • Changing the Perspective for ""Successful"" Maintenance Therapy 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/2/2019

Press Mentions

  • Oncologists Debate Using Maintenance Bevacizumab in Stage IIIc Ovarian Cancer
    Oncologists Debate Using Maintenance Bevacizumab in Stage IIIc Ovarian CancerOctober 28th, 2019
  • Targeting Stem-like Cells Could Prevent Ovarian Cancer Recurrence
    Targeting Stem-like Cells Could Prevent Ovarian Cancer RecurrenceMarch 12th, 2019
  • Findings Support Cancer Stem Cell Model, with Exceptions
    Findings Support Cancer Stem Cell Model, with ExceptionsNovember 30th, 2015
  • Join now to see all

Grant Support

  • Targeting Ovarian Tumor Associated Myeloid Cells With Nanoparticles TherapeuticsNational Cancer Institute2012
  • Using Embryonic Stem Cells To Re-Create A Human Tumor Microenvironment To DevelopOffice Of The Director, National Institutes Of Health2008